1. Home
  2. XBIT vs UHG Comparison

XBIT vs UHG Comparison

Compare XBIT & UHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.41

Market Cap

75.0M

Sector

Health Care

ML Signal

HOLD

Logo United Homes Group Inc

UHG

United Homes Group Inc

HOLD

Current Price

$1.22

Market Cap

68.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
XBIT
UHG
Founded
2005
N/A
Country
United States
United States
Employees
N/A
195
Industry
Pharmaceuticals and Biotechnology
Homebuilding
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
75.0M
68.8M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
XBIT
UHG
Price
$2.41
$1.22
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
21.3K
184.3K
Earning Date
05-08-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.09
$0.99
52 Week High
$3.61
$4.78

Technical Indicators

Market Signals
Indicator
XBIT
UHG
Relative Strength Index (RSI) 38.96 51.41
Support Level $2.35 $1.15
Resistance Level $2.41 $1.22
Average True Range (ATR) 0.06 0.02
MACD -0.02 0.01
Stochastic Oscillator 4.00 70.00

Price Performance

Historical Comparison
XBIT
UHG

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

About UHG United Homes Group Inc

United Homes Group Inc designs, builds and sells homes in high growth markets, including South Carolina, North Carolina, and Georgia. UHG employs a land-light operating, with a focus on the design, construction and sale of entry-level, first, second and third move-up single-family houses. The company principally builds detached single-family houses, and, to a lesser extent, attached single-family houses, including duplex houses and town houses. The company has three reportable segments: GSH South Carolina, Rosewood, and Other.

Share on Social Networks: